SNCI (Sonic Innovations)
All Pro Portfolios with SNCI
All Do-It-Yourself Portfolios with SNCI
- Total Do-It-Yourself Portfolios with SNCI:
- Primo Pickings
- danrey's picks
- March 2007
- D&B TK
- smj10j's Portfolio
- gbertett Portfolio 1
- Stocks Big Poppa is Evaluating, but has not pulled trigger
- ESILANO Portfolio 1
- d mangin Portfolio 1
- otooly Portfolio 1
- peetre Portfolio 1
- bygrace06 Portfolio 1
- Cramer Picks starting October 2007
- greg329149
- patriciakitty Portfolio 1
- barbaraperch
- NavtejS Portfolio 1
- ksardo Portfolio 1
- adevaru Portfolio 1
- Jan/ Feb Conf Calls 2008 Nymph Take
- show more
- 40
- Scott Shuda Portfolio 1
- grizden Portfolio 1
- am627846 Portfolio 1
- OracleofMN Portfolio 1
- Dalekoprovidek1
- letsseewhathappens
- Mercury
- jssmonk Portfolio 1
- Cacique Small Growth
- SUPRATRADE SMALL CAP "BIG APPLE"
- chudbert Portfolio 1
- Conference Calls for October 2007 Nymph Style
- BIONIC WOMAN....we can rebuild her!
- ajitram Portfolio 1
- brandycole2
- john_prodaniuk Portfolio 1
- rbstr44 Mad Money Watch List
- RKS
- Basket
- tc4g
- News For Selected Stock
- Related stories on theStreet.com
- videos related to etf's
- No videos found
- blogs related to etf's
- No blogs found
Why I Love This Stock |
|
By:waynem |
Date:11 28 07 |
Baby Boomer Play |
|
Not yet rated
Rate now:
|
|
By:rbstr44 |
Date:10 29 07 |
With an aging population, the hearing aid market is guaranteed. According to JC, these guys have a tiny, onobtrusive model that should market and sell well. |
|
Not yet rated
Rate now:
|
|
By:NavtejS |
Date:10 22 07 |
New industry profitable. |
|
Not yet rated
Rate now:
|
|
By:greg329149 |
Date:10 16 07 |
cramer select |
|
Not yet rated
Rate now:
|
|
Date:10 06 07 |
|
Maker of Hearing Aids around the world. 243.12 M Cap., Qt Growth 16.40%,Gross Margin 60.96%, Est Yr Growth 200%...no earnings so this a spec play. "Jamie what do you hear" |
|
Not yet rated
Rate now:
|
|
Date:04 02 07 |
|
Good technicals |
|
Not yet rated
Rate now:
|
|
By:am627846 |
Date:04 02 07 |
Great turn around story they made bad decision with testing division it's now sold off and stock is climbing with a top of line product. |
|
Not yet rated
Rate now:
|
|
Why I Hate This Stock |
|
| Comments not available |